* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download VE-cadherin (C-19): sc-6458
Survey
Document related concepts
5-Hydroxyeicosatetraenoic acid wikipedia , lookup
Cytokinesis wikipedia , lookup
Cell growth wikipedia , lookup
Tissue engineering wikipedia , lookup
Cell encapsulation wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell culture wikipedia , lookup
Cellular differentiation wikipedia , lookup
Signal transduction wikipedia , lookup
List of types of proteins wikipedia , lookup
Transcript
SANTA CRUZ BIOTECHNOLOGY, INC. VE-cadherin (C-19): sc-6458 The Power to Question BACKGROUND APPLICATIONS Ca2+-dependent The cadherins are a family of adhesion molecules that function to mediate cell-cell binding critical to the maintenance of tissue structure and morphogenesis. Cadherins each contain a large extracellular domain at the amino terminus, which is characterized by a series of five homologous repeats, the most distal of which is thought to be responsible for binding specificity. The relatively short carboxy terminal, intracellular domain interacts with a variety of cytoplasmic proteins, including β-catenin, to regulate cadherin function. VE-cadherin (for vascular endothelial-cadherin, also designated cadherin-5) is localized at intercellular junctions of endothelial cells, where it is thought to play a role in the cohesion and organization of intercellular junctions. VE-cadherin (C-19) is recommended for detection of VE-cadherin of mouse, rat and human origin by Western Blotting (starting dilution 1:200, dilution range 1:100-1:1000), immunoprecipitation [1–2 µg per 100–500 µg of total protein (1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution range 1:50-1:500) and flow cytometry (1 µg per 1 x 106 cells). Suitable for use as control antibody for VE-cadherin siRNA (h): sc-36814 and VE-cadherin siRNA (m): sc-36813. Molecular Weight of VE-cadherin: 130 kDa. Positive Controls: rat placenta extract or HUV-EC-C whole cell lysate. DATA REFERENCES 1. Takeichi, M. 1988. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102: 639-655. 132 K 90 K 2. Hatta, M., et al. 1991. Genomic organization and chromosomal mapping of the mouse P-cadherin gene. Nucl. Acids Res. 19: 4437-4441. 55 K 3. Koch, P.J., et al. 1994. Desmosomal cadherins: another growing multigene family of adhesion molecules. Curr. Opin. Cell Biol. 6: 682-687. 4. Ranscht, B. 1994. Cadherins and catenins: interactions and functions in embryonic development. Curr. Opin. Cell Biol. 6: 740-746. 5. Ayalon, O., et al. 1994. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J. Cell Biol. 126: 247-258. < VE-cadherin 43 K VE-cadherin (C-19): sc-6458. Western blot analysis of VE-cadherin expression in rat placenta extract. SELECT PRODUCT CITATIONS 6. Takeichi, M. 1995. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7: 619-627. 1. Tinsley, J.H., et al. 1999. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J. Biol. Chem. 274: 24930-24934. 7. Brevario, F., et al. 1995. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb. Vasc. Biol. 15: 1229-1239. 2. Ukropec, J.A., et al. 2000. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J. Biol. Chem. 275: 5983-5986. CHROMOSOMAL LOCATION 3. Ozaki, M., et al. 2002. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am. J. Pathol. 160: 1335-1344. Genetic locus: CDH5 (human) mapping to 16q22.1; Cdh5 (mouse) mapping to 8 D3. SOURCE 4. Shay-Salit, A., et al. 2002. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 99: 9462-9467. VE-cadherin (C-19) is an affinity purified goat polyclonal antibody raised against a peptide mapping at the C-terminus of VE-cadherin of human origin. 5. Wu, W., et al. 2003. VEGF receptor expression and signaling in human bladder tumors. Oncogene 22: 3361-3370. PRODUCT 6. Potter, M., et al. 2005. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and β-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 280: 31906-31912. Each vial contains 200 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin. Blocking peptide available for competition studies, sc-6458 P, (100 µg peptide in 0.5 ml PBS containing < 0.1% sodium azide and 0.2% BSA). Available as phycoerythrin conjugate for flow cytometry, sc-6458 PE, 100 tests. STORAGE Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of shipment. Non-hazardous. No MSDS required. RESEARCH USE For research use only, not for use in diagnostic procedures. Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 fax 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com